moran cohen, LLC

unit 46
flowery branch, georgia, 30542

NYS Entity Status
ACTIVE

NYS Filing Date
OCTOBER 01, 2014

NYS DOS ID#
4644553

County
ERIE

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - MORAN COHEN, LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • A Deli Where Rye Comes in Slices and in a Glass
    By ROBERT SIMONSON - Wednesday Nov 15, 2017

    A branch of the Second Avenue Deli is opening an upstairs bar where you can raise a toast (using a Dr. Brown’s) to Jewish culture.

    Source: NYT > Home Page
  • Women of Sex Tech, Unite
    By ANNA NORTH - Friday Aug 18, 2017

    New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.

    Source: NYT > Home Page
  • The Top 10 Moments of New York Fashion Week
    By THE NEW YORK TIMES - Friday Sep 15, 2017

    Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.

    Source: NYT > Home Page
  • Dylan Moran On Choosing (Not) To Joke About Trump During His ‘Grumbling Mustard’ Tour
    By Andrew Husband - Wednesday Oct 4, 2017

    Irish comedian Dylan Moran discuss the finer points of (not) discussing Donald Trump during the U.S. leg of his 'Grumbling Mustard' tour.

    Source: Uproxx
  • Steven Cohen, Billionaire Collector, Gives $50 Million to MoMA
    By ROBIN POGREBIN - Tuesday Jun 27, 2017

    The foundation of Mr. Cohen and his wife, Alexandra, donated the money to the museum’s capital campaign, and a gallery will be named for them.

    Source: NYT > Home Page
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York